Improved coping and self-efficacy drive improvements in mood among caregivers of patients with primary malignant brain tumors: Results from a randomized controlled trial
Authors:
- Kelcie D WillisKWKelcie D Willis
- Deborah A ForstDFDeborah A Forst
- Nora HorickNHNora Horick
- Sumita M StranderSSSumita M Strander
- Jessica WhitmanJWJessica Whitman
- Timothy SannesTSTimothy Sannes
- Jennifer S TemelJTJennifer S Temel
- Joseph A GreerJGJoseph A Greer
- Areej El-JawahriAEAreej El-Jawahri
- Jamie M JacobsJJJamie M Jacobs
- 20 April 2026
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (7) , 1741-1752
Abstract
Background: In a recent randomized controlled trial, caregivers of patients diagnosed with primary malignant brain tumors (PMBT) who received NeuroCARE—a 6-session, cognitive-behavioral, telehealth intervention—demonstrated improved anxiety and depression symptoms at 11 weeks post-randomization compared to caregivers assigned to usual care (UC). We explored whether these intervention effects were mediated by improvements in coping and self-efficacy. Methods: We examined data from caregivers of patients with PMBT randomized to receive either NeuroCARE or UC (N = 120). Participants completed assessments of anxiety and depression symptoms (Hospital Anxiety and Depression Scale), coping (Measure of Current Status), and self-efficacy (Lewis Cancer Self-Efficacy Scale) at baseline, 11 weeks, and 16 weeks. We conducted 4 simple mediation regression models using the Preacher & Hayes bootstrapping method to examine whether improvements in coping or self-efficacy from baseline to 11 weeks mediated intervention effects on 11-week anxiety or depression symptoms. Results: The sample (N = 120; Mage = 53 years) predominantly consisted of participants who self-identified as female (82.5%), White (91.7%), and spouses/partners (70.0%) caring for a patient with glioblastoma (84%). Improvements in 11-week anxiety symptoms in caregivers assigned to NeuroCARE were mediated by improved coping (indirect effect = −1.44, SE = 0.49, 95% CI [−2.50, −0.54]) and self-efficacy (indirect effect=−1.29, SE = 0.42, 95% CI [−2.16, −0.52]). Similarly, improvements in 11-week depression symptoms were mediated by improved coping (indirect effect=-1.43, SE = 0.38, 95% CI [−2.21, −0.74]) and self-efficacy (indirect effect = −0.95, SE = 0.32, 95% CI [−1.60, −0.36]). Conclusion: The NeuroCARE intervention improves mood by enhancing coping skills and improving caregivers’ self-efficacy in caregivers of patients with PMBT.Keywords
Funding Information
- American Society of Clinical Oncology’s Conquer Cancer Foundation (2019CDA-7743456038)
- National Institute of Health (T32CA092203)
This publication has 48 references indexed in Scilit:
- Caring for the brain tumor patient: Family caregiver burden and unmet needsNeuro-Oncology, 2008
- The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary diseaseHealth and Quality of Life Outcomes, 2008
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Impact of coping skills intervention with family caregivers of hospice patients with cancerCancer, 2005
- When the Caregiver Needs Care: The Plight of Vulnerable CaregiversAmerican Journal of Public Health, 2002
- Social-cognitive predictors of health behavior: Action self-efficacy and coping self-efficacy.Health Psychology, 2000
- Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression ScaleGeneral Hospital Psychiatry, 1993
- Does coping help? A reexamination of the relation between coping and mental health.Journal of Personality and Social Psychology, 1987
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- The effects of psychological stress upon performance.Psychological Bulletin, 1952